Patient leaflet - Desloratadine Teva
B. PACKAGE LEAFLET
Package leaflet: Information for the patient
Desloratadine Teva 5 mg film-coated tablets
Desloratadine
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
-
– Keep this leaflet. You may need to read it again.
-
– If you have any further questions, ask your doctor or pharmacist.
-
– This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if
their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet :
-
1. What Desloratadine Teva is and what it is used for
-
2. What you need to know before you take Desloratadine Teva
-
3. How to take Desloratadine Teva
-
4. Possible side effects
-
5. How to store Desloratadine Teva
-
6. Contents of the pack and other information
1. What Desloratadine Teva is and what it is used for
What Desloratadine Teva is
Desloratadine Teva contains desloratadine which is an antihistamine.
How Desloratadine Teva works
Desloratadine Teva is an antiallergy medicine that does not make you drowsy. It helps control your allergic reaction and its symptoms.
When Desloratadine Teva should be used
Desloratadine Teva relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older. These symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red or watery eyes.
Desloratadine Teva is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). These symptoms include itching and hives.
Relief of these symptoms lasts a full day and helps you to resume your normal daily activities and sleep.
2. What you need to know before you take Desloratadine Teva
Do not take Desloratadine Teva
- if you are allergic to desloratadine, or any of the other ingredients of this medicine (listed in section 6) or to loratadine.
Warnings and precautions
Talk to your doctor or pharmacist before taking Desloratadine Teva
- if you have poor kidney function.
- if you have medical or familial history of seizures.
Use in children and adolescents
Do not give this medicine to children less than 12 years of age.
Other medicines and Desloratadine Teva
There are no known interactions of Desloratadine Teva with other medicines.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Desloratadine Teva with food, drink and alcohol
Desloratadine Teva may be taken with or without a meal.
Use caution when taking Desloratadine Teva with alcohol.
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Taking Desloratadine Teva is not recommended if you are pregnant or nursing a baby.
Fertility
There is no data available on male/female fertility.
Driving and using machines
At the recommended dose, this medicine is not expected to affect your ability to drive or use machines.
Although most people do not experience drowsiness, it is recommended not to engage in activities requiring mental alertness, such as driving a car or operating machinery until you have established your own response to the medicinal product.
Desloratadine Teva contains lactose
Desloratadine Teva contains lactose. If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicine.
3. How to take Desloratadine Teva
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Adults and adolescents 12 years of age and over
The recommended dose is one tablet once a day with water, with or without food.
This medicine is for oral use.
Swallow the tablet whole.
Regarding the duration of treatment, your doctor will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Desloratadine Teva.
If your allergic rhinitis is intermittent (presence of symptoms for less than 4 days per week or for less than 4 weeks), your doctor will recommend you a treatment schedule that will depend on the evaluation of the history of your disease.
If your allergic rhinitis is persistent (presence of symptoms for 4 days or more per week and for more than 4 weeks), your doctor may recommend you a longer term treatment.
For urticaria, the duration of treatment may be variable from patient to patient and therefore you should follow the instructions of your doctor.
If you take more Desloratadine Teva than you should
Take Desloratadine Teva only as it is prescribed for you. No serious problems are expected with accidental overdose. However, if you take more Desloratadine Teva than you were told to, tell your doctor, pharmacist or nurse immediately.
If you forget to take Desloratadine Teva
If you forget to take your dose on time, take it as soon as possible and then go back to your regular dosing schedule. Do not take a double dose to make up for a forgotten dose.
If you stop taking Desloratadine Teva
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
During the marketing of Desloratadine Teva, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) have been reported very rarely. If you notice any of these serious side effects, stop taking the medicine and seek urgent medical advice straight away.
In clinical studies in adults, side effects were about the same as with a dummy tablet. However, fatigue, dry mouth and headache were reported more often than with a dummy tablet. In adolescents, headache was the most commonly reported side effect.
In clinical studies with desloratadine, the following side effects were reported as:
Common: the following may affect up to 1 in 10 people
- fatigue
- dry mouth
- headache
Adults
During the marketing of Desloratadine Teva, the following side effects were reported as:
Very rare: the following may affect up to 1 in 10,000 people
| ||
body movement |
Not known: frequency cannot be estimated from the available data
- unusual weakness yellowing of the skin and/or eyes
- increased sensitivity of the skin to the sun, even in case of hazy sun, and to UV light, for instance to UV lights of a solarium
- changes in the way the heart beats
- abnormal behaviour
- aggression
- weight increased
- increased appetite
Children
Not known: frequency cannot be estimated from the available data
- slow heartbeat change in the way the heart beats
- abnormal behaviour aggression
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
You can also report side effects directly via the national reporting system listed in Appendix V *. By reporting side effects you can help provide more information on the safety of this medicine.
5. How to store Desloratadine Teva
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after “EXP”. The expiry date refers to the last day of that month.
This medicinal product does not require any special storage conditions.
Do not use this medicine if you notice any change in the appearance of the tablets.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Desloratadine Teva contains
-
– The active substance is 5 mg desloratadine.
-
– The other ingredients are microcrystalline cellulose, pregelatinised maize starch, talc, silica colloidal anhydrous, lactose monohydrate, hypromellose, titanium dioxide (E171), macrogol 400, indigo carmine (E132).
What Desloratadine Teva looks like and contents of the pack
Blue, round, biconvex film-coated tablet, plain on both sides. Desloratadine Teva 5 mg film-coated tablets are supplied in blister packs of 7, 10, 14, 20, 21, 28, 30, 40, 50, 60, 90, 100 and 105 film-coated tablets and in perforated blister packs of 50 × 1 film-coated tablet (unit dose). Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer
Marketing Authorisation Holder
Teva B.V.
Swensweg 5
2031 GA Haarlem
The Netherlands
Manufacturer
TEVA Pharmaceutical Works Private Limited Company
Pallagi ut 13,
4042 Debrecen,
Hungary or
Pharmachemie B.V.
Swensweg 5, 2031 GA Haarlem, The Netherlands or
Merckle GmbH
Ludwig-Merckle-Strasse 3
D-89143 Blaubeuren
Germany
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder:
Belgie/Belgique/Belgien Teva Pharma Belgium N.V./S.A./AG Tél/Tel: +32 38207373 | Lietuva UAB Teva Baltics Tel: +370 52660203 |
Etnrapua TeBa OapMa EAfl Ten: +359 24899585 | Luxembourg/Luxemburg Teva Pharma Belgium N.V./S.A./AG Belgique/Belgien Tel/Tel: +32 38207373 |
Česká republika Teva Pharmaceuticals CR, s.r.o. Tel: +420 251007111 | Magyarorszag Teva Gyogyszergyar Zrt. Tel: +36 12886400 |
Danmark Teva Denmark A/S Tlf: +45 44985511 | Malta Teva Pharmaceuticals Ireland L-Irlanda Tel: +44 2075407117 |
Deutschland TEVA GmbH Tel: +49 73140208 | Nederland Teva Nederland B.V. Tel: +31 8000228400 |
Eesti | Norge Teva Norway AS |
UAB Teva Baltics Eesti filiaal | Tlf: +47 66775590 |
Tel: +372 6610801
EXÀàôa Specifar A.B.E.E. Tql: +30 2118805000 | Österreich ratiopharm Arzneimittel Vertriebs-GmbH Tel: +43 1970070 |
España Teva Pharma, S.L.U. Tel: +34 913873280 | Polska Teva Pharmaceuticals Polska Sp. z o.o. Tel: +48 223459300 |
France Teva Santé Tél: +33 155917800 | Portugal Teva Pharma – Produtos Farmacéuticos, Lda. Tel: +351 214767550 |
Hrvatska Pliva Hrvatska d.o.o. Tel: + 385 13720000 | Romania Teva Pharmaceuticals S.R.L. Tel: +40 212306524 |
Ireland Teva Pharmaceuticals Ireland Tel: +44 2075407117 | Slovenija Pliva Ljubljana d.o.o. Tel: +386 15890390 |
Ísland
Alvogen ehf.
Sími: +354 5222900
Italia
Teva Italia S.r.l.
Tel: +39 028917981
Kùnpoç
Specifar A.B.E.E.
EMáSa
Tql: +30 2118805000
Latvija
UAB Teva Baltics filiale Latvijä
Tel: +371 67323666
Slovenská republika
TEVA Pharmaceuticals Slovakia s.r.o.
Tel: +421 257267911
Suomi/Finland
SanoSwiss UAB
Puh/Tel: +370 70001320
Sverige
Teva Sweden AB
Tel: +46 42121100
United Kingdom (Northern Ireland)
Teva Pharmaceuticals Ireland
Ireland
Tel: +44 2075407117
This leaflet was last revised in
Detailed information on this medicine is available on the European Medicines Agency web site:
23